FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4298266990> ?p ?o ?g. }

• W4298266990 endingPage "173" @default.
• W4298266990 startingPage "1" @default.
• W4298266990 abstract "Naphthalene is used as an intermediate in the synthesis of phthalic and anthranilic acids, naphthols, naphthylamines, sulfonic acid, synthetic resins, celluloid, and hydronaphthalenes; it is also used in the preparation of anthraquinone, indigo, salicylic acid, and 1-naphthyl-N-methylcarbamate insecticide. It is an ingredient in some moth repellants and toilet bowl deodorants; it is also used in veterinary medicine in antiseptics for irrigating animal wounds and as an external medication to control lice on livestock and poultry. Naphthalene was selected for study by the National Toxicology Program because previous inhalation studies with naphthalene in mice were positive and existing studies in rats were either considered inadequate or were conducted via routes other than inhalation. Male and female F344/N rats were exposed to naphthalene (greater than 99% pure) by inhalation for 2 years. Genetic toxicology studies were conducted in Salmonella typhimurium and cultured Chinese hamster ovary cells. 2-YEAR STUDY: Groups of 49 male and 49 female rats were exposed to naphthalene by inhalation at concentrations of 0, 10, 30, or 60 ppm for 6 hours plus T90 (12 minutes) per day, 5 days per week for 105 weeks. Additional groups of nine male and nine female rats were exposed to 10, 30, or 60 ppm for up to 18 months for evaluation of toxicokinetic parameters. Survival, Body Weights, and Gross Observations: The survival of all exposed groups of male and female rats was similar to that of the chamber controls. Mean body weights of all exposed groups of males were less than those of the chamber control group throughout most of the study. Masses were observed in the nose of male and female rats. These masses frequently partially occluded the nasal passages or obliterated the normal architecture of the nasal turbinates. Pathology Findings: The incidences of neuroblastoma of the olfactory epithelium, a rare neoplasm, occurred with positive trends in males and females. Because this neoplasm did not occur in chamber control rats or in male rats exposed to 10 ppm and because this neoplasm has not been seen in the historical chamber control rats in NTP 2-year inhalation studies, the increased incidences of neuroblastoma were considered to be related to naphthalene exposure. In males, the incidences of adenoma of the respiratory epithelium of the nose, another rare neoplasm, occurred with a positive trend and were significantly increased in all exposed groups; none occurred in the chamber controls. In females, these neoplasms occurred in the 30 and 60 ppm groups but not in the chamber control or 10 ppm groups. Because these neoplasms did not occur in the chamber controls and have not been observed in the historical chamber control rats in NTP 2-year inhalation studies, the incidences of nasal adenoma were considered to be related to naphthalene exposure. Increased incidences of nonneoplastic lesions of the nose associated with exposure to naphthalene included atypical hyperplasia, atrophy, chronic inflammation, and hyaline degeneration of the olfactory epithelium; hyperplasia, squamous metaplasia, hyaline degeneration, and goblet cell hyperplasia of the respiratory epithelium; and glandular hyperplasia and squamous metaplasia. Toxicokinetic Results Model: A physiologically based toxicokinetic model was developed to characterize the disposition of inhaled naphthalene in rats. Because of its low vapor pressure and high blood-to-air partition coefficient, essentially all of the naphthalene that is absorbed into the general circulation is metabolized. At the exposure concentrations used in the 2-year study, approximately 20% to 30% of the inhaled dose was metabolized by male and female rats. Naphthalene that was not absorbed during exposure was assumed to be exhaled. The respective estimated daily doses metabolized by rats exposed to 10, 30, or 60 ppm for 6 hours (i.e., the internalized doses) are 3.6, 10.7, and 20.1 mg naphthalene/kg body weight for males and 3.9, 11.4, and 20.6 mg/kg for females.Naphthalene was not mutagenic in any of four strains of Salmonella typhimurium with or without induced liver S9 enzymes. However, in cytogenetic tests with cultured Chinese hamster ovary cells, naphthalene induced significant increases in sister chromatid exchanges with and without metabolic activation (S9) and in chromosomal aberrations with S9. Naphthalene did not induce chromosomal aberrations in the absence of S9 activation.Under the conditions of this 2-year inhalation study, there was clear evidence of carcinogenic activity of naphthalene in male and female F344/N rats based on increased incidences of respiratory epithelial adenoma and olfactory epithelial neuroblastoma of the nose. In male and female rats, exposure to naphthalene caused significant increases in the incidences of non-neoplstic lesions of the nose." @default.
• W4298266990 created "2022-10-01" @default.
• W4298266990 date "2000-12-01" @default.
• W4298266990 modified "2023-10-18" @default.
• W4298266990 title "Toxicology and carcinogenesis studies of naphthalene (cas no. 91-20-3) in F344/N rats (inhalation studies)." @default.
• W4298266990 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11725561" @default.
• W4298266990 hasPublicationYear "2000" @default.
• W4298266990 type Work @default.
• W4298266990 citedByCount "12" @default.
• W4298266990 countsByYear W42982669902016 @default.
• W4298266990 countsByYear W42982669902019 @default.
• W4298266990 countsByYear W42982669902020 @default.
• W4298266990 countsByYear W42982669902022 @default.
• W4298266990 countsByYear W42982669902023 @default.
• W4298266990 crossrefType "report" @default.
• W4298266990 hasConcept C114246631 @default.
• W4298266990 hasConcept C178790620 @default.
• W4298266990 hasConcept C185592680 @default.
• W4298266990 hasConcept C2776954882 @default.
• W4298266990 hasConcept C2779255514 @default.
• W4298266990 hasConcept C2779777708 @default.
• W4298266990 hasConcept C33070731 @default.
• W4298266990 hasConcept C42219234 @default.
• W4298266990 hasConcept C42407357 @default.
• W4298266990 hasConcept C71924100 @default.
• W4298266990 hasConcept C86803240 @default.
• W4298266990 hasConceptScore W4298266990C114246631 @default.
• W4298266990 hasConceptScore W4298266990C178790620 @default.
• W4298266990 hasConceptScore W4298266990C185592680 @default.
• W4298266990 hasConceptScore W4298266990C2776954882 @default.
• W4298266990 hasConceptScore W4298266990C2779255514 @default.
• W4298266990 hasConceptScore W4298266990C2779777708 @default.
• W4298266990 hasConceptScore W4298266990C33070731 @default.
• W4298266990 hasConceptScore W4298266990C42219234 @default.
• W4298266990 hasConceptScore W4298266990C42407357 @default.
• W4298266990 hasConceptScore W4298266990C71924100 @default.
• W4298266990 hasConceptScore W4298266990C86803240 @default.
• W4298266990 hasIssue "500" @default.
• W4298266990 hasLocation W42982669901 @default.
• W4298266990 hasOpenAccess W4298266990 @default.
• W4298266990 hasPrimaryLocation W42982669901 @default.
• W4298266990 hasRelatedWork W1518918137 @default.
• W4298266990 hasRelatedWork W152205697 @default.
• W4298266990 hasRelatedWork W2007472894 @default.
• W4298266990 hasRelatedWork W2021564288 @default.
• W4298266990 hasRelatedWork W2030050628 @default.
• W4298266990 hasRelatedWork W2151392864 @default.
• W4298266990 hasRelatedWork W2413532272 @default.
• W4298266990 hasRelatedWork W3132313114 @default.
• W4298266990 hasRelatedWork W4236114655 @default.
• W4298266990 hasRelatedWork W2047959265 @default.
• W4298266990 isParatext "false" @default.
• W4298266990 isRetracted "false" @default.
• W4298266990 workType "report" @default.